Navigation Links
Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
Date:7/30/2008

ture financial position, future financial results, plans and objectives of management are forward-looking statements. We may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Various important factors that could cause actual results or events to differ materially from the forward-looking statements that we make are described in greater detail in the reports we file with Securities and Exchange Commission, including the "Risk Factors" section in Item 1 of the Form 10-KSB we filed with the Securities and Exchange Commission on March 27, 2008. Nile is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.


'/>"/>
SOURCE Nile Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2014)... VIENNA , September 3, 2014 /PRNewswire/ ...   to be located in the ... Nabriva Therapeutics AG, a biotechnology company ... antibiotics for the treatment of serious infections caused by ... Broom as Chief Executive Officer (CEO). Current CEO Ralf Schmid will ...
(Date:9/3/2014)... ,    ~ Clinical ... Kiadis Pharma B.V. ("Kiadis Pharma", ... developing T-cell immunotherapy treatments for blood cancers, today announces ... PhD, as its Chief Medical Officer. Jeroen ... Biosciences. Prior to that he was VP Medical Affairs ...
(Date:9/3/2014)... BUDAPEST, Hungary , Sept. 3, 2014 /PRNewswire/ ... "Palatin") and Gedeon Richter Plc. (hereinafter: "Richter") announced ... license agreement to co-develop and commercialize bremelanotide for ... Union, other European countries and additional selected countries.  ... a strong focus in female health and annual ...
Breaking Medicine Technology:Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 2Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 3Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 2Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 3Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 5Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 2Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 3Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 4Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 5
... Sigma-Aldrich Corporation (NASDAQ: SIAL ) will ... KeyBanc Capital Markets 2011 Basic Materials ... InterContinental, Boston, MA, presenting at 9:00 AM (Eastern). ... at the Grand Hyatt, New York, NY, presenting at ...
... SimonMed and Cox Business have partnered to make a ... patients in the Valley and across the state at ... is the first dedicated outpatient offering of breast tomosynthesis ... in Scottsdale. Sub-specialty trained radiologists at SimonMed ...
Cached Medicine Technology:Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences 2SimonMed and Cox Business Bring Breast Tomosynthesis to Arizona 2
(Date:9/3/2014)... Angeles, CA (PRWEB) September 03, 2014 ... is hosting a free webinar called “Google Hates ... the live presentation will reveal common problems that render ... – and offer strategies to overcome them. , The ... 10th, beginning at 11am PST (2 pm EST), and ...
(Date:9/3/2014)... Viejo, California (PRWEB) September 03, 2014 ... new ProStatic Lesson from Pixel Film Studios. , “ProStatic ... TV and VCR static to special effect artist,” said ... users customizable options to create the static distortion based ... static effects of an old television or VCR in ...
(Date:9/3/2014)... (PRWEB) September 03, 2014 Londi Palmisano, ... to offer an innovative solution for people looking for ... muscles of the back and upper body. In a ... really innovative and functional design for promoting increased flexibility ... body weight, and a gentle rocking motion. , Then, ...
(Date:9/3/2014)... Mila Carlson, PhD, RN, CLNC, CNLCP, ... healthcare provider. Celebrating 5 years of successful service ... of the National Alliance of Certified Legal ... Consultants, American Association of Legal Nurse Consultants-Greater Chicago ... Care Planners. , Dr. Carlson’s background is ...
(Date:9/3/2014)... Seattle, Wa (PRWEB) September 03, 2014 ... report created by Nguyen Do on the site Vkool.com, ... on health and beauty, and provides detailed instructions on ... of this report, people will discover some reasons to ... soothes chapped lips ,     It may protect against ...
Breaking Medicine News(10 mins):Health News:Fred Joyal Webinar Warns Dentists: Google Hates Your Website 2Health News:Fred Joyal Webinar Warns Dentists: Google Hates Your Website 3Health News:A New ProStatic Lesson was Released Today from Pixel Film Studios Exclusively for Final Cut Pro X 2Health News:Body Archer's Solution for Perfect Back Stretching Sparks Interest Among Health Care Pros 2Health News:Mila Carlson & Associates, P.C., Celebrates 5 Years of Excellence in Business Serving as a Legal Nurse Consultant and Nurse Life Care Planner 2Health News:Mila Carlson & Associates, P.C., Celebrates 5 Years of Excellence in Business Serving as a Legal Nurse Consultant and Nurse Life Care Planner 3Health News:“Health And Beauty Benefits Of Olive Oil,” a New Report on Vkool.com, Reveals to People the Benefits of Olive Oil on Health and Beauty 2Health News:“Health And Beauty Benefits Of Olive Oil,” a New Report on Vkool.com, Reveals to People the Benefits of Olive Oil on Health and Beauty 3
... found the survival rate of non-small-cell lung cancer ... adjuvant chemotherapy. Cisplatin is an anti-neoplastic medication that ... slows their growth and spread in the body. ... receive either three or four cycles of cisplatin-based ...
... the world's first epilepsy drug, an Australian neurologist says.// ... a mild sedative, taken either as a herbal infusion ... form. ,But the Italian author Fabio Colonna first ... botanical work Phytobasanos. ,Colonna said he had controlled ...
... dads who have children at an older age may ... in life. ,Researchers based their analysis on ... between 1989 and 2001 with a diagnosis of schizophrenia ... strong association between the fathers' age at conception and ...
... use stomach-acid suppressive medications for indigestion or gastroesophageal reflux ... of developing pneumonia .// ,The use of ... infections, as stomach acidity is a major defense mechanism ... than 364,000 patients who did and did not use ...
... say they have found that the drug toremifene, also ... decreased patients' cancer incidence after 12 months of treatment. ... but the 20-milligram dose had the greatest effect. ... neoplasia, characterized by abnormal cells in the lining of ...
... that sleep disorders may be linked to other medical ... neuromuscular conditions, and psychiatric problems. ,Researchers conducted a ... apnea also had ADD. Results also show a high ... showed some of these patients also suffered severe memory ...
Cached Medicine News:Health News:Valerian was first epilepsy drug 2
... BBL CHROMagar MRSA is a differential ... and/or confirmation of MRSA. Selective agents ... gram-negative organisms, most strains of S. ... the chromogenic substrate resulting in mauve ...
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
... The Apex light source is equipped with a ... higher efficiency light collection and energy transfer from the ... a 730 lumen output, which is equivalent to higher ... use of a lower watt bulb reduces the amount ...
... Understanding the need to standardize your ... a comprehensive line of optical couplers to ... Linvatec offers standard "C and "V mount ... fog free cartridge designs. We also offer ...
Medicine Products: